UB Paderborn / Katalog / Suche / in CDI

Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma

Nature medicine, 2019-12, Vol.25 (12), p.1916-1927

2019

Link zum Volltext

Verfügbarkeit prüfen

Neurological Immune Related Adverse Events Associated with Nivolumab, Ipilimumab, and Pembrolizumab Therapy-Review of the Literature and Future Outlook

Journal of clinical medicine, 2019-10, Vol.8 (11), p.1777

2019

Link zum Volltext

Verfügbarkeit prüfen

The mTOR-inhibitor Sirolimus decreases the cyclosporine-induced expression of the oncogene ATF3 in human keratinocytes

Journal of dermatological science, 2018-11, Vol.92 (2), p.172-180

2018

Link zum Volltext

Verfügbarkeit prüfen

Effects of mammalian target of rapamycin inhibitors on cytokine production and differentiation in keratinocytes

Experimental dermatology, 2016-10, Vol.25 (10), p.775-782

2016

Link zum Volltext

Verfügbarkeit prüfen

Salvage therapy after failure from anti-PD-1 single agent treatment: A Study by the German ADOReg melanoma registry

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.9505-9505

2019

Link zum Volltext

Verfügbarkeit prüfen

Staphylococcal Exotoxins Induce Interleukin 22 in Human Th22 Cells

International archives of allergy and immunology, 2014-01, Vol.165 (1), p.35-39

2014

Link zum Volltext

Verfügbarkeit prüfen

Intrinsic alterations of pro-inflammatory mediators in unstimulated and TLR-2 stimulated keratinocytes from atopic dermatitis patients

Experimental dermatology, 2011-06, Vol.20 (6), p.468-472

2011

Link zum Volltext

Verfügbarkeit prüfen

Risk Factors for Developing Nonmelanoma Skin Cancer after Lung Transplantation

Journal of skin cancer, 2019-01, Vol.2019, p.7089482-11

2019

Link zum Volltext

Verfügbarkeit prüfen

Early Exanthema Upon Vemurafenib Plus Cobimetinib Is Associated With a Favorable Treatment Outcome in Metastatic Melanoma: A Retrospective Multicenter DeCOG Study

Frontiers in oncology, 2021-05, Vol.11, p.672172-672172

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinics, prognosis and new therapeutic options in patients with mucosal melanoma: A retrospective analysis of 75 patients

Medicine (Baltimore), 2017-01, Vol.96 (1), p.e5753-e5753

2017

Link zum Volltext

Verfügbarkeit prüfen

Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity

European journal of cancer (1990), 2017-04, Vol.75, p.24-32

2017

Link zum Volltext

Verfügbarkeit prüfen

MicroRNA‐15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma

International journal of cancer, 2010-06, Vol.126 (11), p.2553-2562

2010

Link zum Volltext

Verfügbarkeit prüfen

Melanoma-specific survival in patients with positive sentinel lymph nodes: Relevance of sentinel tumor burden

European journal of cancer (1990), 2019-12, Vol.123, p.83-91

2019

Link zum Volltext

Verfügbarkeit prüfen

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Journal der Deutschen Dermatologischen Gesellschaft, 2020-12, Vol.18 (12), p.1495-1497

2020

Link zum Volltext

Verfügbarkeit prüfen

Serious skin toxicity with the combination of BRAF inhibitors and radiotherapy

Journal of clinical oncology, 2013-05, Vol.31 (13), p.e220-e222

2013

Link zum Volltext

Verfügbarkeit prüfen

Impact of American Joint Committee on Cancer 8th edition classification on staging and survival of patients with melanoma

European journal of cancer (1990), 2019-09, Vol.119, p.18-29

2019

Link zum Volltext

Verfügbarkeit prüfen

Treatment-related hemophagocytic lymphohistiocytosis secondary to checkpoint inhibition with nivolumab plus ipilimumab

European journal of cancer (1990), 2018-04, Vol.93, p.150-153

2018

Link zum Volltext

Verfügbarkeit prüfen

Combination of denosumab and immune checkpoint inhibition: experience in 29 patients with metastatic melanoma and bone metastases

Cancer Immunology, Immunotherapy, 2019-07, Vol.68 (7), p.1187-1194

2019

Link zum Volltext

Verfügbarkeit prüfen

microRNA-21 is upregulated in malignant melanoma and influences apoptosis of melanocytic cells

Experimental dermatology, 2012-07, Vol.21 (7), p.509-514

2012

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma

European journal of cancer (1990), 2017-08, Vol.81, p.36-44

2017

Link zum Volltext

Verfügbarkeit prüfen

The hand-foot-syndrome associated with medical tumor therapy - classification and management

Journal der Deutschen Dermatologischen Gesellschaft, 2010-09, Vol.8 (9), p.652-661

2010

Link zum Volltext

Verfügbarkeit prüfen

Erfolgreiche Behandlung eines metastasierenden Melanoms mit Talimogen laherparepvec (T‐VEC) bei einer lebertransplantierten Patientin

Journal der Deutschen Dermatologischen Gesellschaft, 2020-12, Vol.18 (12), p.1495-1497

2020

Link zum Volltext

Verfügbarkeit prüfen

Successful treatment of a metastatic melanoma with Talimogen laherparepvec (T‐VEC) in a liver transplant patient

Journal der Deutschen Dermatologischen Gesellschaft, 2020-12, Vol.18 (12), p.1495-1497

2020

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma

The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network

Neurological Immune Related Adverse Events Associated with Nivolumab, Ipilimumab, and Pembrolizumab Therapy-Review of the Literature and Future Outlook

The mTOR-inhibitor Sirolimus decreases the cyclosporine-induced expression of the oncogene ATF3 in human keratinocytes

Effects of mammalian target of rapamycin inhibitors on cytokine production and differentiation in keratinocytes

Salvage therapy after failure from anti-PD-1 single agent treatment: A Study by the German ADOReg melanoma registry

Staphylococcal Exotoxins Induce Interleukin 22 in Human Th22 Cells

Author Correction: Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma

Intrinsic alterations of pro-inflammatory mediators in unstimulated and TLR-2 stimulated keratinocytes from atopic dermatitis patients

Risk Factors for Developing Nonmelanoma Skin Cancer after Lung Transplantation

Early Exanthema Upon Vemurafenib Plus Cobimetinib Is Associated With a Favorable Treatment Outcome in Metastatic Melanoma: A Retrospective Multicenter DeCOG Study

Clinics, prognosis and new therapeutic options in patients with mucosal melanoma: A retrospective analysis of 75 patients

Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity

MicroRNA‐15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma

Melanoma-specific survival in patients with positive sentinel lymph nodes: Relevance of sentinel tumor burden

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Serious skin toxicity with the combination of BRAF inhibitors and radiotherapy

Impact of American Joint Committee on Cancer 8th edition classification on staging and survival of patients with melanoma

Treatment-related hemophagocytic lymphohistiocytosis secondary to checkpoint inhibition with nivolumab plus ipilimumab

Combination of denosumab and immune checkpoint inhibition: experience in 29 patients with metastatic melanoma and bone metastases

microRNA-21 is upregulated in malignant melanoma and influences apoptosis of melanocytic cells

Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma

The hand-foot-syndrome associated with medical tumor therapy - classification and management

Erfolgreiche Behandlung eines metastasierenden Melanoms mit Talimogen laherparepvec (T‐VEC) bei einer lebertransplantierten Patientin

Successful treatment of a metastatic melanoma with Talimogen laherparepvec (T‐VEC) in a liver transplant patient

Suchergebnisse filtern